Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pathology Differences Distinguish CTE from Azheimer's Disease

By LabMedica International staff writers
Posted on 01 Apr 2019
Neurological disease researchers have found an important difference that distinguishes the molecular pathology of Chronic Traumatic Encephalopathy (CTE) from that of Alzheimer's disease (AD).

CTE is a neurodegenerative tauopathy - a pathological aggregation of tau protein in neurofibrillary or gliofibrillary tangles in the brain - that is associated with repetitive head impacts or exposure to blast waves. More...
It was described first as "punch-drunk syndrome" and dementia pugilistica in retired boxers, but has since been identified in former participants of other contact sports, ex-military personnel, and after physical abuse. No disease-modifying therapies currently exist, and diagnosis requires an autopsy. In AD, tau undergoes chemical changes, becoming hyperphosphorylated; it then begins to pair with other threads, creating neurofibrillary tangles and disintegrating the neuron's transport system.

Investigators at Indiana University School of Medicine (Indianapolis, USA) used cryo-electron microscopy (cryo-EM) to demonstrate a fundamental difference between the tau tangles of CTE and those of AD. Cryo-EM is an analytical technique that provides near-atomic structural resolution without requirements for crystallization or limits on molecular size and complexity imposed by the other techniques. Cryo-EM allows the observation of specimens that have not been stained or fixed in any way, showing them in their native environment while integrating multiple images to form a three-dimensional model of the sample.

The investigators determined the structures of tau filaments from the brains of three individuals with CTE at resolutions down to 2.3 Angstroms, using cryo-electron microscopy. They showed that filament structures were identical in the three cases but were distinct from those of Alzheimer’s and Pick’s diseases, and from those formed in vitro. In CTE, a different conformation of the beta-helix region created a hydrophobic cavity that was absent in tau filaments from the brains of patients with Alzheimer’s disease. This cavity enclosed an additional density that was not connected to tau, which suggested that the incorporation of cofactors may have a role in tau aggregation in CTE. The discovery of the difference between pathogenic tau of CTE and that of AD offers options for improved diagnosis and potential targeted treatments.

Contributing author Dr. Ruben Vidal, professor in the of pathology and laboratory medicine at Indiana University School of Medicine, said, "These two new discoveries provide more insights into CTE than had previously existed. The information will be incredibly valuable for the development of novel agents to help in diagnosis and therapeutics specifically designed for individuals fighting CTE."

The cryo-EM study was published in the March 20, 2019, online edition of the journal Nature.

Related Links:
Indiana University School of Medicine


Gold Member
Hematology Analyzer
Medonic M32B
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.